Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.

Gain a deeper understanding of how sirolimus coated balloon (SCB) technology is shaping the treatment of complex coronary artery disease (CAD). This EuroPCR 2025 session brings together compelling clinical trial data and real-world case presentations to illustrate the safety, efficacy, and versatility of the MagicTouch SCB...

Gain insights into acute and late coronary complications following TAVI. This session discusses angina post-TAVI, mechanisms of acute severe mitral regurgitation during TAVR, hidden coronary obstructions, sudden hemodynamic collapse, and acute coronary occlusion after balloon aortic valvuloplasty.

Register for free to this webinar on Monday 12 January at 5:00pm (UTC+1) with H. Mölmann, R. Hahn, W-K. Kim and P. Lauten, and discuss different sources of complexity in TAVI and much more!

Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2025 Scientific Sessions #ACC25

The humble and noble ambition of SHARE (Sustain Health development in Africa through Responsible Education) is to identify a favorable environment in sub-Saharan countries where catheter labs can be established.

SHARE is turning its attention to Mali in West Africa with a view to duplicating the Mauritanian experience. Find our more about how this NGO helps to save lives!

Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...

Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)

The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.

Over 11,000 participants from around the globe are once again expected at EuroPCR – a Course tailored for interventional cardiologists, cardiac surgeons, imaging specialists, radiologists, nurses, allied professionals and other practitioners, as well as researchers, innovators and industry representatives. They will be sharing their knowledge, skills and experience on...

Francesco Costa reports live on late-breaking trials of interest for the interventional community presented at ACC 2019: AUGUSTUS, GLASSY, TICAGRELOR REVERSAL, DEFINE PCI and MRUSMI.

Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.